Weigh In on Medicare Cost Measures by Nov. 20

What are your thoughts on how Medicare attributes costs to you or your practice in its incentive and penalty programs?

Are they working out for you? Or do you agree with TMA that they are inaccurate and unfair?

Either way, the Centers for Medicare & Medicaid Services (CMS) is testing and developing new methods to identify and attribute relevant Medicare costs, and they want your feedback.

As required by the Medicare Access and CHIP Reauthorization Act (MACRA), CMS is developing new measures for future use in the cost performance category of the Merit-Based Incentive Payment System (MIPS) under the Quality Payment Program. Specifically, CMS wants to know what physicians think of eight episode-based cost measures: 

  1. Elective outpatient percutaneous coronary intervention (PCI),
  2. Knee arthroplasty,
  3. Revascularization for lower extremity chronic critical limb ischemia,
  4. Routine cataract removal with intraocular lens implantation,
  5. Screening/surveillance colonoscopy,
  6. Intracranial hemorrhage or cerebral infarction,
  7. Simple pneumonia with hospitalization, and 
  8. ST-elevation myocardial infarction with PCI.

If you or your practice performs or manages the care for one or more of the procedures or medical conditions, look for the field test reports for your practice on the CMS Enterprise Portal and give feedback to CMS through this online survey by Nov. 20.

For complete details, refer to the CMS fact sheet or FAQs. For questions about the cost measures or feedback process, email CMS

After you provide feedback, contact TMA by emailing Donna Kinney, and let us know what you told CMS.   

Action, Nov. 1, 2017

Last Updated On

November 15, 2017

Related Content

CHIP | MACRA | Medicaid | Medicare